IXHL
NASDAQ · Pharmaceuticals
Incannex Healthcare Inc
$3.09
+0.01 (+0.32%)
Open$3.04
Previous Close$3.08
Day High$3.16
Day Low$3.02
52W High$27.69
52W Low$2.49
Volume—
Avg Volume92.3K
Market Cap37.21M
P/E Ratio—
EPS$-12.90
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 901.9K | 1.70M | 25.07M |
| Net Income | -491,631,284 | -832,019,848 | 4.81M |
| Profit Margin | -54,517.4% | -51,791.6% | 19.2% |
| EBITDA | -262,304,745 | -468,577,487 | 6.46M |
| Free Cash Flow | — | — | 4.01M |
| Rev Growth | -46.8% | -46.8% | +16.3% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |